Form 8-K - Current report:
SEC Accession No. 0001628280-24-047433
Filing Date
2024-11-13
Accepted
2024-11-13 08:11:57
Documents
44
Period of Report
2024-11-13
Items
Item 7.01: Regulation FD Disclosure
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K xfor-20241113.htm   iXBRL 8-K 40694
2 EX-99.1 a991x4fullphase2cnresultsr.htm EX-99.1 29025
3 EX-99.2 a992corporatepresentatio.htm EX-99.2 35825
7 a992corporatepresentatio001.jpg GRAPHIC 94861
8 a992corporatepresentatio002.jpg GRAPHIC 292036
9 a992corporatepresentatio003.jpg GRAPHIC 76420
10 a992corporatepresentatio004.jpg GRAPHIC 47074
11 a992corporatepresentatio005.jpg GRAPHIC 141695
12 a992corporatepresentatio006.jpg GRAPHIC 97026
13 a992corporatepresentatio007.jpg GRAPHIC 107111
14 a992corporatepresentatio008.jpg GRAPHIC 38842
15 a992corporatepresentatio009.jpg GRAPHIC 130845
16 a992corporatepresentatio010.jpg GRAPHIC 126279
17 a992corporatepresentatio011.jpg GRAPHIC 130709
18 a992corporatepresentatio012.jpg GRAPHIC 126480
19 a992corporatepresentatio013.jpg GRAPHIC 95034
20 a992corporatepresentatio014.jpg GRAPHIC 107341
21 a992corporatepresentatio015.jpg GRAPHIC 96473
22 a992corporatepresentatio016.jpg GRAPHIC 96066
23 a992corporatepresentatio017.jpg GRAPHIC 106887
24 a992corporatepresentatio018.jpg GRAPHIC 97240
25 a992corporatepresentatio019.jpg GRAPHIC 114974
26 a992corporatepresentatio020.jpg GRAPHIC 142401
27 a992corporatepresentatio021.jpg GRAPHIC 81097
28 a992corporatepresentatio022.jpg GRAPHIC 105262
29 a992corporatepresentatio023.jpg GRAPHIC 115748
30 a992corporatepresentatio024.jpg GRAPHIC 140281
31 a992corporatepresentatio025.jpg GRAPHIC 85657
32 a992corporatepresentatio026.jpg GRAPHIC 38386
33 a992corporatepresentatio027.jpg GRAPHIC 91393
34 a992corporatepresentatio028.jpg GRAPHIC 79185
35 x4logo.jpg GRAPHIC 4345
  Complete submission text file 0001628280-24-047433.txt   4407157

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT xfor-20241113.xsd EX-101.SCH 1785
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT xfor-20241113_lab.xml EX-101.LAB 23449
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT xfor-20241113_pre.xml EX-101.PRE 13583
46 EXTRACTED XBRL INSTANCE DOCUMENT xfor-20241113_htm.xml XML 2824
Mailing Address 61 NORTH BEACON STREET 4TH FLOOR BOSTON MA 02134
Business Address 61 NORTH BEACON STREET 4TH FLOOR BOSTON MA 02134 857-529-8300
X4 Pharmaceuticals, Inc (Filer) CIK: 0001501697 (see all company filings)

EIN.: 273181608 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38295 | Film No.: 241451286
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)